Synaptogenix to Present at Hanson Wade 10th Annual Neurodegenerative Drug Development Summit
/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing regenerative therapeutics...
Source: prnewswire.com